Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Short term Debt: 2019

Historic Short term Debt for Avidity Biosciences (RNA) over the last 1 years, with Dec 2019 value amounting to $2.8 million.

  • Avidity Biosciences' Short term Debt was N/A to $2.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2019, which is N/A change from last year.
  • Avidity Biosciences' Short term Debt amounted to $2.8 million in FY2019.
  • Avidity Biosciences' Short term Debt's 5-year high stood at $2.8 million during FY2019, with a 5-year trough of $2.8 million in FY2019.
  • For the 1-year period, Avidity Biosciences' Short term Debt averaged around $2.8 million, with its median value being $2.8 million (2019).